Frontiers in Cell and Developmental BiologyNeurosciencePeer-reviewed journal article
Mitochondrial Proteome of Affected Neurons in a Mouse Model of Leigh Syndrome
Alejandro GellaiD, Patricia Prada-DacasaiD, Montserrat CarrascaliD, Andrea UrpiiD, Melania González-TorresiD, Joaquín AbiániD, Elisenda SanziD, Albert QuintanaiD
Abstract
Defects in mitochondrial function lead to severe neuromuscular orphan pathologies known as mitochondrial disease. Among them, Leigh Syndrome is the most common pediatric presentation, characterized by symmetrical brain lesions, hypotonia, motor and respiratory deficits, and premature death. Mitochondrial diseases are characterized by a marked anatomical and cellular specificity. However, the molecular determinants for this susceptibility are currently unknown, hindering the efforts to find an effective treatment. Due to the complex crosstalk between mitochondria and their supporting cell, strategies to assess the underlying alterations in affected cell types in the context of mitochondrial dysfunction are critical. Here, we developed a novel virus-based tool, the AAV-mitoTag viral vector, to isolate mitochondria from genetically-defined cell types. Administration of the AAV-mitoTag in the vestibular neurons of a mouse model of Leigh Syndrome lacking the complex I subunit Ndufs4 allowed us to assess the proteome and acetylome of susceptible neurons in a well characterized model recapitulating the human disease. Our results show a marked reduction of complex-I N-module subunit abundance and an increase in the levels of the assembly factor NDUFA2. Transiently-associated non-mitochondrial proteins such as PKC{delta}, and the complement subcomponent C1Q were also increased in Ndufs4-deficient mitochondria. Furthermore, lack of Ndufs4 induced pyruvate dehydrogenase (PDH) subunit hyperacetylation, leading to decreased PDH activity. We provide novel insight on the pathways involved in mitochondrial disease, which could underlie potential therapeutic approaches for these pathologies.
- Citations
- 16
- FWCI
- 0.81
- Field percentile
- top 32%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defined neuronal populations drive fatal phenotype in Leigh Syndrome
Irene Bolea, Alejandro Gella, … Albert Quintana·eLifePeer-reviewed·Aug 12, 2019
- Iron Status Influences Mitochondrial Disease Progression in Complex I-Deficient Mice
CJ Kelly, Reid K Couch, … Anthony S. Grillo·eLifePeer-reviewed·Feb 17, 2023
- Dysfunctional LHX6 pallido-subthalamic projections mediate epileptic events in a mouse model of Leigh Syndrome
Laura Sánchez-Benito, Melania González-Torres, … Albert Quintana·Journal of Clinical InvestigationPeer-reviewed·Oct 2, 2025
- Gene replacement therapy provides benefit in an adult mouse model of Leigh syndrome
Robin Reynaud-Dulaurier, Giorgia Benegiamo, … Mickaël Decressac·BrainPeer-reviewed·Mar 18, 2020
- MyD88 deficiency modestly attenuates disease in a Leigh syndrome mouse model while enrofloxacin accelerates disease
Allison Rose Hanaford, Elizaveta A. Olkhova, … Simon C. Johnson·Journal of Neuropathology & Experimental NeurologyPeer-reviewed·Sep 4, 2026
- Impaired Complex I dysregulates neural/glial precursors and corpus callosum development revealing postnatal defects in Leigh Syndrome mice
Sahitya Ranjan Biswas, Porter L. Tomsick, … Alicia M. Pickrell·EMBO Molecular MedicinePeer-reviewed·Dec 22, 2025